Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies integrates transcriptomic research and RNA-based therapeutics to understand and treat atherosclerosis, emphasizing the power of genetic insights to revolutionize cardiovascular medicine. This book fills an essential gap by offering up-to-date insights into molecular mechanisms, diagnostic innovations, and therapeutic strategies, fostering a new era of personalized cardiovascular care. Specifically, readers will find information on cutting-edge RNA sequencing methods, clinical translation and multi-omics integration; as well as phenotyping and treatment stratification, complemented by a multi-omics approach to provide a holistic view of vascular pathology. “Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies” provides a deep understanding of disease mechanisms and potential interventions. Of great interest to readers will be the focus on RNA-based biomarkers and therapeutics for early detection, monitoring, and targeted interventions in atherosclerosis. Additionally, advanced transcriptomic technologies and their applications presents an illuminating exploration of novel RNA sequencing methods, including single-cell and spatial transcriptomics, and how they unveil the complexities of atherosclerotic disease. This book will doubtlessly be the one reached for by medical professionals seeking edification in this bourgeoning field.

• Unravels the molecular intricacies of atherosclerosis using the latest transcriptomic technologies, offering new perspectives on disease mechanisms and potential therapeutic targets
• Highlights the transformative potential of RNA molecules in advancing diagnostics and developing novel RNA-based treatments for personalized medicine in cardiovascular care
• Provides actionable insights into translating transcriptomic findings into clinical applications, enhancing patient stratification, and treatment strategies